accountAPP first company to offer all three dosage forms SCHAUMBURG, Ill., May 19, 2011 (BUSINESS WIRE) -- APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to APP Pharmaceuticals Announces Approval and Launch of Gemcitabine HCI for Injection, USP in 2 Gram Dosage Form
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account